Cargando…
The Proteasome Activator PA200/PSME4: An Emerging New Player in Health and Disease
Proteasomes comprise a family of proteasomal complexes essential for maintaining protein homeostasis. Accordingly, proteasomes represent promising therapeutic targets in multiple human diseases. Several proteasome inhibitors are approved for treating hematological cancers. However, their side effect...
Autores principales: | Yazgili, Ayse Seda, Ebstein, Frédéric, Meiners, Silke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406137/ https://www.ncbi.nlm.nih.gov/pubmed/36009043 http://dx.doi.org/10.3390/biom12081150 |
Ejemplares similares
-
In-gel proteasome assay to determine the activity, amount, and composition of proteasome complexes from mammalian cells or tissues
por: Yazgili, Ayse Seda, et al.
Publicado: (2021) -
Proteasome activator PA200 regulates myofibroblast differentiation
por: Welk, Vanessa, et al.
Publicado: (2019) -
Tumors escape immunosurveillance by overexpressing the proteasome activator PSME3
por: Boulpicante, Mathilde, et al.
Publicado: (2020) -
Cryo-EM structures of the human PA200 and PA200-20S complex reveal regulation of proteasome gate opening and two PA200 apertures
por: Guan, Hongxin, et al.
Publicado: (2020) -
Proteasome activators, PA28γ and PA200, play indispensable roles in male fertility
por: Huang, Lin, et al.
Publicado: (2016)